Alphabet life science subsidiary Verily recently received U.S. Food and Drug Administration (FDA) clearance for its wearable smartwatch’s EKG feature. The smartwatch—named Study Watch—is able to record, store, transfer, and display single-channel EKG rhythms.
EKG, which stands for electrocardiogram, is a paper or digital recording of the electrical signals in the heart. Verily feels that mobile health tools such as the Study Watch add a new method to understanding how the body works and how to do things like keep it healthy and help it adapt to disease. The news comes not long after the news in December that the Apple Watch 4 would contain EKG features.
Alphabet Inc. is an American multinational conglomerate created in a corporate restructuring of Google on October 2, 2015. It is now the parent company of Google and several former Google subsidiaries, such as Verily.
This was reported by Med City News on January 22, 2019.
Contact Information: Alphabet Inc., 1600 Amphitheatre Parkway, Mountain View, California 94043; (650) 253-0000; Website: www.abc.xyz